Publication: Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy.
No Thumbnail Available
Identifiers
Date
2018-04-19
Authors
Otero, Remedios
Bertoletti, Laurent
Muriel, Alfonso
Siniscalchi, Carmine
Jimenez, Carmen
Luis Lobo, Jose
Kigitovica, Dana
Quintavalla, Roberto
Rocci, Anna
Jara-Palomares, Luis
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
European Respiratory Society
Metrics
Export
Abstract
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and serious complication after pulmonary embolism (PE). Its incidence in the general population is around 3–30 cases per million. The incidence of CTEPH after acute PE ranges between 0.1 and 8.8% [1–5]. In a meta-analysis including 4047 PE patients, the incidence of CTEPH was 2.8% (95% CI 1.5–4.1) in “PE survivors” without major comorbidities [6]. In studies not using objective diagnostic criteria to diagnose CTEPH, the pooled incidence was 6.3% (95% CI 4.1–8.4)
Description
MeSH Terms
Echocardiography
Humans
Predictive Value of Tests
Registries
Thromboembolism
Humans
Predictive Value of Tests
Registries
Thromboembolism
DeCS Terms
Incidencia
Embolia pulmonar
Hipertensión pulmonar
Tromboembolia venosa
Enfermedad aguda
Embolia pulmonar
Hipertensión pulmonar
Tromboembolia venosa
Enfermedad aguda
CIE Terms
Keywords
Decision Support Techniques, Europe, Hypertension, Pulmonary, Pulmonary Embolism
Citation
Otero R, Bertoletti L, Muriel A, Siniscalchi C, Jimenez C, Luis Lobo J, et al. Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy. Eur Respir J. 2018 Apr 19;51(4):1702576.